Synthesis and anti Methicillin resistant Staphylococcus aureus activity of substituted chalcones alone and in combination with non-beta-lactam antibiotics

This publication has 40 references indexed in Scilit:

• Current review of antimicrobial treatment of nosocomial pneumonia caused by multidrug-resistant pathogens
  Expert Opinion on Pharmacotherapy, 2011
• Synergy-Directed Fractionation of Botanical Medicines: A Case Study with Goldenseal (Hydrastis canadensis)
  Journal of Natural Products, 2011
• The third-generation P-glycoprotein inhibitor tariquidar may overcome bacterial multidrug resistance by increasing intracellular drug concentration
  Journal of Antimicrobial Chemotherapy, 2011
• Impact of the Recent Mouse P‐Glycoprotein Structure for Structure‐Based Ligand Design
  Molecular Informatics, 2010
• Telavancin
  Nature Reviews Drug Discovery, 2009
• Inhibitory activity of prostaglandin E2 production by the synthetic 2′-hydroxychalcone analogues: Synthesis and SAR study
  Bioorganic & Medicinal Chemistry Letters, 2009
• Computational models for prediction of interactions with ABC-transporters
  Drug Discovery Today, 2008
• 6,7-Dihydroxyflavone Dramatically Intensifies the Susceptibility of Methicillin-Resistant or -Sensitive Staphylococcus aureus to β-Lactams
  Antimicrobial Agents and Chemotherapy, 2004
• Inhibition of bacterial efflux pumps: a new strategy to combat increasing antimicrobial agent resistance
  Expert Opinion on Emerging Drugs, 2002
• The Protein Data Bank
  Nucleic Acids Research, 2000